PGNY Progyny, Inc.

Nasdaq progyny.com


$ 24.50 $ 0.13 (0.53 %)    

Friday, 14-Nov-2025 15:55:00 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 24.55
$ 24.07
$ 24.55 x 71
$ 24.60 x 658
$ 23.88 - $ 24.72
$ 13.39 - $ 26.76
1,418,404
na
2.12B
$ 1.29
$ 37.42
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-03-2025 01-01-1970 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 02-29-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-04-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-04-2022 09-30-2022 10-Q
14 08-05-2022 06-30-2022 10-Q
15 05-06-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-08-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-06-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-10-2020 12-31-2019 10-K
25 12-06-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-upgrades-progyny-to-overweight-announces-30-price-target

Keybanc analyst Scott Schoenhaus upgrades Progyny (NASDAQ:PGNY) from Sector Weight to Overweight and announces $30 price tar...

 jp-morgan-maintains-neutral-on-progyny-raises-price-target-to-26

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $25 to $26.

 progyny-raises-fy2025-adj-eps-guidance-from-170-178-to-179-182-vs-062-est-raises-fy2025-sales-guidance-from-1235b-1270b-to-1263b-1278b-vs-1259b-est

Full Year 2025 Outlook:Revenue is now projected to be $1.263 billion to $1.278 billion, reflecting growth of 8.2% to 9.5%; excl...

 progyny-sees-q4-2025-adj-eps-037-040-vs-014-est-sees-sales-292700m-307700m-vs-302589m-est

Fourth Quarter of 2025 Outlook:Revenue is projected to be $292.7 million to $307.7 million, reflecting a change of (1.9)% to 3....

Core News & Articles

- Reuters

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

Core News & Articles

https://www.nytimes.com/2025/10/16/us/politics/trump-ivf-fertility.html

 jp-morgan-maintains-neutral-on-progyny-raises-price-target-to-25

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $23 to $25.

 canaccord-genuity-maintains-hold-on-progyny-raises-price-target-to-23

Canaccord Genuity analyst Richard Close maintains Progyny (NASDAQ:PGNY) with a Hold and raises the price target from $21 to ...

 cantor-fitzgerald-maintains-overweight-on-progyny-raises-price-target-to-28

Cantor Fitzgerald analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $26...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION